Sigma Healthcare Limited (S5YA) - Total Assets
Based on the latest financial reports, Sigma Healthcare Limited (S5YA) holds total assets worth €1.83 Billion EUR (≈ $2.14 Billion USD) as of January 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check S5YA total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Sigma Healthcare Limited - Total Assets Trend (2017–2025)
This chart illustrates how Sigma Healthcare Limited's total assets have evolved over time, based on quarterly financial data. Explore Sigma Healthcare Limited (S5YA) investment intensity to see how much of total assets are deployed in long-term investments.
Sigma Healthcare Limited - Asset Composition Analysis
Current Asset Composition (January 2025)
Sigma Healthcare Limited's total assets of €1.83 Billion consist of 75.2% current assets and 24.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.8% |
| Accounts Receivable | €1.53 Billion | 83.5% |
| Inventory | €383.44 Million | 21.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €19.65 Million | 1.1% |
| Goodwill | €89.06 Million | 4.9% |
Asset Composition Trend (2017–2025)
This chart illustrates how Sigma Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Sigma Healthcare Limited.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sigma Healthcare Limited's current assets represent 75.2% of total assets in 2025, a decrease from 82.1% in 2017.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2025, down from 2.2% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 8.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 83.5% of total assets.
Sigma Healthcare Limited Competitors by Total Assets
Key competitors of Sigma Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511
|
China | CN¥35.13 Billion |
|
Medios AG
XETRA:ILM1
|
Germany | €918.23 Million |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
Sigma Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 2.46 | 1.28 |
| Quick Ratio | 1.15 | 1.86 | 0.73 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €511.82 Million | €541.22 Million | €159.99 Million |
Sigma Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Sigma Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.56 |
| Latest Market Cap to Assets Ratio | 10.78 |
| Asset Growth Rate (YoY) | 32.9% |
| Total Assets | €1.83 Billion |
| Market Capitalization | $19.74 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Sigma Healthcare Limited's assets at a significant premium (10.78x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Sigma Healthcare Limited's assets grew by 32.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Sigma Healthcare Limited (2017–2025)
The table below shows the annual total assets of Sigma Healthcare Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-01-31 | €1.83 Billion ≈ $2.14 Billion |
+32.85% |
| 2024-01-31 | €1.38 Billion ≈ $1.61 Billion |
+17.36% |
| 2023-01-31 | €1.17 Billion ≈ $1.37 Billion |
-5.94% |
| 2022-01-31 | €1.25 Billion ≈ $1.46 Billion |
+3.54% |
| 2021-01-31 | €1.21 Billion ≈ $1.41 Billion |
-0.53% |
| 2020-01-31 | €1.21 Billion ≈ $1.42 Billion |
-12.41% |
| 2019-01-31 | €1.38 Billion ≈ $1.62 Billion |
+5.78% |
| 2018-01-31 | €1.31 Billion ≈ $1.53 Billion |
+16.92% |
| 2017-01-31 | €1.12 Billion ≈ $1.31 Billion |
-- |
About Sigma Healthcare Limited
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemi… Read more